Echocardiography in newly diagnosed atrial fibrillation patients: A systematic review and economic evaluation

Health Technology Assessment

Volumn 17, Issue 36, 2013, Pages 1-263

  Simpson, E L ^a   Stevenson, M D ^a   Scope, A ^a   Poku, E ^a   Minton, J ^a   Evans, P ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; DABIGATRAN ETEXILATE; PLACEBO; RIVAROXABAN; WARFARIN;

AGE; ANTICOAGULATION; BLEEDING; CEREBROVASCULAR ACCIDENT; CHADS2 SCORE; CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG COST; ECONOMIC EVALUATION; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MATHEMATICAL MODEL; MORTALITY; PREVALENCE; PROGNOSIS; QUALITY ADJUSTED LIFE YEAR; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; THROMBOEMBOLISM; TRANSTHORACIC ECHOCARDIOGRAPHY; VALVULAR HEART DISEASE;

ADULT; AGE DISTRIBUTION; AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; CARDIOVASCULAR DISEASES; COMORBIDITY; COST-BENEFIT ANALYSIS; ECHOCARDIOGRAPHY; FEMALE; GREAT BRITAIN; HEMORRHAGE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MASS SCREENING; MIDDLE AGED; PREVALENCE; QUALITY-ADJUSTED LIFE YEARS; RESPIRATORY INSUFFICIENCY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STROKE;

EID: 84883475527     PISSN: 13665278     EISSN: 20464924     Source Type: Journal    
DOI: 10.3310/hta17360     Document Type: Review

References (213)

1. The National Collaborating Centre for Chronic Conditions. Atrial fibrillation: national clinical guideline for management in primary and secondary care. 2006. URL: www.nice.org.uk/nicemedia/ live/10982/30055/30055.pdf.
2. Fuster V, Ryden LE, Cannom, DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. 2011 ACCF/AHA/ HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. Circulation 2011;123:e269-367. http://dx.doi.org/10.1161/ CIR.0b013e318214876d
3. Levy S, Camm AJ, Saksena S, Aliot E, Breithardt G, Crijns H, et al. International consensus on nomenclature and classification of atrial fibrillation. Europace 2003;5:119-22. http://dx.doi. org/10.1053/eupc.2002.0300
4. Estes NAM, Sacco RL, Al-Khatib SM, Ellinor PT, Bezanson J, Alonso A, et al. American Heart Association Atrial Fibrillation Research Summit. Circulation 2011;124:363-72. http://dx.doi. org/10.1161/CIR.0b013e318224b037
5. Kerr CR, Humphries KH, Talajic M, Klein GJ, Connolly SJ, Green M, et al. Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation. Am Heart J 2005;149:489-96. http://dx.doi.org/10.1016/j. ahj.2004.09.053
6. Developed with the special contribution of the European Heart Rhythm Association (EHRA), Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS), Task FM, Camm AJ, Kirchhof P, Lip GYH, et al. Guidelines for the management of atrial fibrillation. Eur Heart J 2010;31:2369-429.
7. Olson JM, Samad BA, Alam M. Prognostic value of pulse-wave tissue Doppler parameters in patients with systolic heart failure. Am J Cardiol 2008;102:722-5. http://dx.doi.org/10.1016/j. amjcard.2008.04.054
8. Pizko P, Lewczuk J, Lenatowska L, Jagas J, Romaszkiewicz R, Blaszczyk D, et al. Pulmonary thromboembolism in 102 consecutive patients with chronic atrial fibrillation. Diagnostic value of echocardiography. Kardiol Pol 2007;65:246-51.
9. Okura H, Takada Y, Kubo T, Iwata K, Mizoguchi S, Taguchi H, et al. Tissue Doppler-derived index of left ventricular filling pressure, E/E', predicts survival of patients with non-valvular atrial fibrillation. Heart 2006;92:1248-52. http://dx.doi.org/10.1136/hrt.2005.082594
10. Sakabe K, Fukuda N, Fukuda Y, Morishita S, Shinohara H, Tamura Y, et al. Transthoracic echocardiography during sinus rhythm identifies elderly patients with nonvalvular paroxysmal atrial fibrillation at high risk of cerebral infarction. Int J Cardiol 2009;136:346-8. http://dx.doi. org/10.1016/j.ijcard.2008.04.065
11. Thambidorai SK, Murray RD, Parakh K, Shah TK, Black IW, Jasper SE, et al. Utility of transesophageal echocardiography in identification of thrombogenic milieu in patients with atrial fibrillation (an ACUTE ancillary study). Am J Cardiol 2005;96:935-41. http://dx.doi.org/10.1016/j. amjcard.2005.05.051
12. Bernhardt P, Schmidt H, Hammerstingl C, Luderitz B, Omran H. Patients at high risk with atrial fibrillation: a prospective and serial follow-up during 12 months with transesophageal echocardiography and cerebral magnetic resonance imaging. J Am Soc Echocardiogr 2005;18:919-24. http://dx.doi.org/10.1016/j.echo.2005.01.028
13. Providencia R, Botelho A, Trigo J, Quintal N, Nascimento J, Mota P, et al. Possible refinement of clinical thromboembolism assessment in patients with atrial fibrillation using echocardiographic parameters. Europace 2012;14:36-45. http://dx.doi.org/10.1093/europace/eur272
14. Kannel WB, Benjamin EJ. Current perceptions of the epidemiology of atrial fibrillation. Cardiol Clin 2009;27:13-vii.
15. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370-5. http://dx.doi.org/10.1001/jama.285.18.2370
16. Stewart S, Hart CL, Hole DJ, McMurray JJ. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study. Heart 2001;86:516-21. http://dx.doi.org/10.1136/ heart.86.5.516
17. Ryder KM, Benjamin EJ. Epidemiology and significance of atrial fibrillation. Am J Cardiol 1999;84:131-8R. http://dx.doi.org/10.1016/S0002-9149(99)00713-4
18. Stewart S. Epidemiology and economic impact of atrial fibrillation. J Cardiovasc Nurs 2004;19:94-102.
19. Kannel WBW. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998;82:2N-9N. http://dx.doi.org/10.1016/ S0002-9149(98)00583-9
20. Kannel WB, Benjamin EJ. Status of the epidemiology of atrial fibrillation. Med Clin N Am 2008;92:17-40. http://dx.doi.org/10.1016/j.mcna.2007.09.002
21. Majeed A, Moser K, Carroll K. Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994-1998: analysis of data from the general practice research database. Heart 2001;86:284-8. http://dx.doi.org/10.1136/heart.86.3.284
22. Murphy NF, Simpson CR, Jhund PS, Stewart S, Kirkpatrick M, Chalmers J, et al. A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland. Heart 2007;93:606-12. http://dx.doi.org/10.1136/hrt.2006.107573
23. Lip GY, Beevers DG. ABC of atrial fibrillation. History, epidemiology, and importance of atrial fibrillation. BMJ 1995;311:1361-3. http://dx.doi.org/10.1136/bmj.311.7016.1361
24. Wolf PAB. Secular trends in the prevalence of atrial fibrillation: the Framingham study. Am Heart J 1996;131:790-5. http://dx.doi.org/10.1016/S0002-8703(96)90288-4
25. Lip GY, Bawden L, Hodson R, Rutland E, Snatchfold J, Beevers DG. Atrial fibrillation amongst the Indo-Asian general practice population. The West Birmingham Atrial Fibrillation Project. Int J Cardiol 1998;65:187-92.
26. Rienstra M, Hagens VE, van Veldhuisen DJ, Bosker HA, Tijssen JG, Kamp O, et al. Clinical characteristics of persistent lone atrial fibrillation in the RACE study. Am J Cardiol 2004;94:1486-90. http://dx.doi.org/10.1016/j.amjcard.2004.08.024
27. Aronow WS, Ahn C, Kronzon I, Gutstein H. Association of left ventricular hypertrophy and chronic atrial fibrillation with the incidence of new thromboembolic stroke in 2,384 older persons. Am J Cardiol 1999;84:468-9, A9.
28. de Divitiis M, Omran H, Rabahieh R, Rang B, Illien S, Schimpf R, et al. Right atrial appendage thrombosis in atrial fibrillation: its frequency and its clinical predictors. Am J Cardiol 1999;84:1023-8. http://dx.doi.org/10.1016/S0002-9149(99)00492-0
29. Chugh SS, Blackshear JL, Shen WK, Hammill SC, Gersh BJ. Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol 2001;37:371-8. http://dx.doi.org/10.1016/ S0735-1097(00)01107-4
30. Miyasaka Y, Barnes ME, Petersen RC, Cha SS, Bailey KR, Gersh BJ, et al. Risk of dementia in strokefree patients diagnosed with atrial fibrillation: data from a community-based cohort. Eur Heart J 2007;28:1962-7. http://dx.doi.org/10.1093/eurheartj/ehm012
31. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death. Circulation 1998;98:946-52. http://dx.doi.org/10.1161/01.CIR.98.10.946
32. Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med 2002;113:359-64. http://dx.doi.org/10.1016/S0002-9343(02)01236-6
33. Mitra R, Leatham EW. Admissions with atrial fibrillation: disease patterns and outcomes in a District General Hospital. QJM 2005;98:153-4. http://dx.doi.org/10.1093/qjmed/hci021
34. Stewart S, MacIntyre K, MacLeod MM, Bailey AE, Capewell S, McMurray JJ. Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland, 1986-1996. Eur Heart J 2001;22:693-701. http://dx.doi.org/10.1053/euhj.2000.2511
35. Stewart S, Murphy NF, Walker A, McGuire A, McMurray JJ. Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK. Heart 2004;90:286-92. http://dx.doi.org/10.1136/ hrt.2002.008748
36. National Service Framework. National Service Framework for Coronary Heart Disease. Chapter 8: arrhythmias and sudden cardiac death. 2005. URL: www.cardiomyopathy.org/assets/files/NSF%20 Chapter%208.pdf (accessed November 2011).
37. Fuster V, Ryden L, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. Circulation 2006;114:700-52. http://dx.doi.org/10.1161/CIRCULATIONAHA.106.177031
38. Van Gelder I, Groenveld H, Crijns H, Tuininga Y, Tijssen J, Alings A, et al. Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med 2010;362:1363-73. http://dx.doi. org/10.1056/NEJMoa1001337
39. AFFIRM Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-33. http://dx.doi.org/10.1056/NEJMoa021328
40. Van Gelder I, Hagens VE, Bosker H, Kingma H, Kamp O, Kingma T, et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002;347:1834-40. http://dx.doi.org/10.1056/NEJMoa021375
41. Roy D, Talajic M, Nattel S, Wyse D, Dorian P, Lee K, et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 2008;358:2667-77. http://dx.doi.org/10.1056/ NEJMoa0708789
42. National Institute for Health and Care Excellence (NICE). NICE guidelines. Cryoablation for atrial fibrillation in association with other cardiac surgery. London: NICE; 2006.
43. Camm A, Kirchhof P, Lip G, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010;31:2369-429. http://dx.doi.org/10.1093/eurheartj/ehq278
44. American Heart Association (AHA) Science Advisory, Knight BP, Gersh BJ, Carlson M, Friedman P, McNamara R, et al. Role of permanent pacing to prevent atrial fibrillation: science advisory from the American Heart Association Council on Clinical Cardiology (Subcommittee on Electrocardiography and Arrhythmias) and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society. Circulation 2005;111:240-3. http://dx.doi. org/10.1161/01.CIR.0000151800.84945.47
45. National Institute for Health and Care Excellence (NICE). Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation. London: NICE; 2012.
46. National Institute for Health and Care Excellence (NICE). Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation. London: NICE; 2012.
47. National Institute for Health and Care Excellence (NICE). Atrial fibrillation (stroke prevention)-rivaroxaban. London: NICE; 2012.
48. Wann LS, Curtis AB, Ellenbogen KA, Estes NAM, Ezekowitz MD, Jackman WM, et al. 2011 ACCF/ AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2011;57:1330-7. http://dx.doi.org/10.1016/j. jacc.2011.01.010
49. Bayliss J (for Bedfordshire and Hertfordshire Cardiac Network). Bedfordshire and Hertfordshire Cardiac Network guidance. Effective use of transthoracic echocardiography (TTE) in adults-summary. 2006. URL: www.bhhsnetwork.nhs.uk/UserFiles/File/StandardsGuidelines/Beds&Herts_ Echo_guidelines_v2_Brief.pdf (accessed November 2011).
50. British Society of Echocardiography. Clinical indications for echocardiography. 2009. URL: http:// cdn1.cache.twofourdigital.net/u/bsecho/media/10465/clinical_indications_for_echocardiography. pdf (accessed November 2011).
51. Evangelista A, Flachskampf FA, Lancellotti P, Badano LP, Aguilar R, Monaghan MJ, et al. European Association of Echocardiography recommendations for standardization of performance, digital storage and reporting of echocardiographic studies. Eur J Echocardiogr 2008;9:438-48. http:// dx.doi.org/10.1093/ejechocard/jen174
52. National Imaging Board. Cardiac imaging: a report from the National Imaging Board. 2010. URL: www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/ DH_114380 (accessed November 2011).
53. Stanko L, Jacobsohn E, Tam J, De Wet C, Avidan M. Transthoracic echocardiography: impact on diagnosis and management in tertiary care intensive care units. Anaesth Intensive Care 2005;33:492-6.
54. Nieuwlaat R, Capucci A, Camm AJ, Olsson SB, Andresen D, Davies DW, et al. Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur Heart J 2005;26:2422-34. http://dx.doi.org/10.1093/eurheartj/ehi505
55. UK National Screening Committee. Screening Criteria set by the UK National Screening Committee. 2011. URL: www.scotland.gov.uk/Topics/Health/health/cancer/Cancer-Screening/criteria (accessed November 2011).
56. Petticrew M, Sowden A, Lister-Sharp D, Wright K. False-negative results in screening programmes: systematic review of impact and implications. Health Technol Assess 2000;4(5).
57. Merlin T, Weston A, Tooher R. Extending an evidence hierarchy to include topics other than treatment: revising the Australian 'levels of evidence'. BMC Med Res Meth 2009;9:(34). http:// dx.doi.org/10.1186/1471-2288-9-34
58. Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stats Med 1998;17:857-72. http://dx.doi.org/10.1002/ (SICI)1097-0258(19980430)17:8(857::AID-SIM77783.0.CO;2-E
59. Whiting P, Rutjes A, Reitsma J, Bossuyt P, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Meth 2003;3:(25). http://dx.doi.org/10.1186/1471-2288-3-25
60. Elm EV, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 2007;335:806-8. http://dx.doi.org/10.1136/bmj.39335.541782.AD
61. Moher D, Liberati A, Tetzlaff J, Altman DG, the PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. Ann Intern Med 2009;151:65-94.
62. Acar J, Cormier B, Grimberg D, Kawthekar G, Iung B, Scheuer B, et al. Diagnosis of left atrial thrombi in mitral stenosis-usefulness of ultrasound techniques compared with other methods. Eur Heart J 1991;12(Suppl. B):70-6. http://dx.doi.org/10.1093/eurheartj/12.suppl_B.70
63. Arques S, Roux E, Sbragia P, Gelisse R, Ambrosi P, Pieri B, et al. Comparative accuracy of color M-mode and tissue Doppler echocardiography in the emergency diagnosis of congestive heart failure in chronic hypertensive patients with normal left ventricular ejection fraction. Am J Cardiol 2005;96:1456-9. http://dx.doi.org/10.1016/j.amjcard.2005.07.051
64. Attenhofer Jost CH, Turina J, Mayer K, Seifert B, Amann FW, Buechi M, et al. Echocardiography in the evaluation of systolic murmurs of unknown cause. Am J Med 2000;108:614-20. http://dx.doi. org/10.1016/S0002-9343(00)00361-2
65. Barron JT, Manrose DL, Liebson PR. Comparison of auscultation with two-dimensional and Doppler echocardiography in patients with suspected mitral valve prolapse. Clin Cardiol 1988;11:401-6. http://dx.doi.org/10.1002/clc.4960110608
66. Bova C, Greco F, Misuraca G, Serafini O, Crocco F, Greco A, et al. Diagnostic utility of echocardiography in patients with suspected pulmonary embolism. Am J Emerg Med 2003;21:180-3. http://dx.doi.org/10.1016/S0735-6757(02)42257-7
67. Casella F, Rana B, Casazza G, Bhan A, Kapetanakis S, Omigie J, et al. The potential impact of contemporary transthoracic echocardiography on the management of patients with native valve endocarditis: a comparison with transesophageal echocardiography. Echocardiography 2009;26:900-6. http://dx.doi.org/10.1111/j.1540-8175.2009.00906.x
68. Cassidy TP, Hardwick DJ, Norris CA. Aortic stenosis in elderly people: an evaluation of clinical and echocardiographic diagnosis. Age Ageing 1992;21:440-4. http://dx.doi.org/10.1093/ ageing/21.6.440
69. Dittmann H, Karsch KR, Seipel L. Diagnosis and quantification of aortic regurgitation by pulsed Doppler echocardiography in patients with mitral valve disease. Eur Heart J 1987;8(Suppl. C):53-7. http://dx.doi.org/10.1093/eurheartj/8.suppl_C.53
70. Enia F, Ledda G, Lo MR, Matassa C, Raspanti G, Stabile A, et al. Utility of echocardiography in the diagnosis of aortic dissection involving the ascending aorta. Chest 1989;95:124-9. http://dx.doi. org/10.1378/chest.95.1.124
71. Erbel R, Schweizer P, Krebs W, Meyer J, Effert S, Erbel R, et al. Sensitivity and specificity of twodimensional echocardiography in detection of impaired left ventricular function. Eur Heart J 1984;5:477-89.
72. Grossmann G, Wohrle J, Kochs M, Giesler M, Hombach V, Hoher M, et al. Quantification of mitral regurgitation by the proximal flow convergence method-comparison of transthoracic and transesophageal echocardiography. Clin Cardiol 2002;25:517-24. http://dx.doi.org/10.1002/ clc.4960251108
73. Groves AM, Win T, Charman SC, Wisbey C, Pepke-Zaba J, Coulden RA, et al. Semi-quantitative assessment of tricuspid regurgitation on contrast-enhanced multidetector CT. Clin Radiol 2004;59:715-19. http://dx.doi.org/10.1016/j.crad.2004.02.007
74. Guyer DE, Gillam LD, Foale RA, Clark MC, Dinsmore R, Palacios I, et al. Comparison of the echocardiographic and hemodynamic diagnosis of rheumatic tricuspid stenosis. J Am Coll Cardiol 1984;3:1135-44. http://dx.doi.org/10.1016/S0735-1097(84)80170-9
75. Helmcke F, Nanda NC, Hsiung MC, Soto B, Adey CK, Goyal RG, et al. Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation 1987;75:175-83. http://dx.doi. org/10.1161/01.CIR.75.1.175
76. Jassal DS, Aminbakhsh A, Fang T, Shaikh N, Embil JM, Mackenzie GS, et al. Diagnostic value of harmonic transthoracic echocardiography in native valve infective endocarditis: comparison with transesophageal echocardiography. Cardiovasc Ultrasound 2007;5:20. http://dx.doi. org/10.1186/1476-7120-5-20
77. Kaymaz C, Ozdemir N, Kirma C, Sismanoglu M, Daglar B, Ozkan M, et al. Location, size and morphological characteristics of left atrial thrombi as assessed by echocardiography in patients with rheumatic mitral valve disease. Eur J Echocardiogr 2001;2:270-6. http://dx.doi.org/10.1053/ euje.2001.0093
78. Kishon Y, Iqbal A, Oh JK, Gersh BJ, Freeman WK, Seward JB, et al. Evolution of echocardiographic modalities in detection of postmyocardial infarction ventricular septal defect and papillary muscle rupture: study of 62 patients. Am Heart J 1993;126:667-75. http://dx.doi. org/10.1016/0002-8703(93)90417-8
79. Kitayama H, Kiuchi K, Endo T, Hayakawa H, Kitayama H, Kiuchi K, et al. Value of cardiac ultrafast computed tomography for detecting right atrial thrombi in chronic atrial fibrillation. Am J Cardiol 1997;79:1292-5. http://dx.doi.org/10.1016/S0002-9149(97)00107-0
80. Lanzarini L, Fontana A, Campana C, Klersy C, Lanzarini L, Fontana A, et al. Two simple echo-Doppler measurements can accurately identify pulmonary hypertension in the large majority of patients with chronic heart failure. J Heart Lung Transplant 2005;24:745-54. http://dx.doi.org/10.1016/j. healun.2004.03.026
81. Maestre A, Gil V, Gallego J, Aznar J, Mora A, Martin-Hidalgo A, et al. Diagnostic accuracy of clinical criteria for identifying systolic and diastolic heart failure: cross-sectional study. J Eval Clin Pract 2009;15:55-61. http://dx.doi.org/10.1111/j.1365-2753.2008.00954.x
82. Mugge A, Daniel WG, Angermann C, Spes C, Khandheria BK, Kronzon I, et al. Atrial septal aneurysm in adult patients: a multicenter study using transthoracic and transesophageal echocardiography. Circulation 1995;91:2785-92. http://dx.doi.org/10.1161/01.CIR.91.11.2785
83. Nienaber CA, von Kodolitsch Y, Nicolas V, Siglow V, Piepho A, Brockhoff C, et al. The diagnosis of thoracic aortic dissection by noninvasive imaging procedures. N Engl J Med 1993;328:1-9. http:// dx.doi.org/10.1056/NEJM199301073280101
84. Nienaber CA, von Kodolitsch Y, Brockhoff CJ, Koschyk DH, Spielmann RP. Comparison of conventional and transesophageal echocardiography with magnetic resonance imaging for anatomical mapping of thoracic aortic dissection. A dual noninvasive imaging study with anatomical and/or angiographic validation. Int J Card Imag 1994;10:1-14. http://dx.doi. org/10.1007/BF01151576
85. Okura H, Fuyuki H, Kubo T, Iwata K, Taguchi H, Toda I, et al. Noninvasive diagnosis of ischemic and nonischemic cardiomyopathy using coronary flow velocity measurements of the left anterior descending coronary artery by transthoracic Doppler echocardiography. J Am Soc Echocardiogr 2006;19:552-8. http://dx.doi.org/10.1016/j.echo.2005.12.013
86. Pochis WT, Saeian K, Sagar KB. Usefulness of transesophageal echocardiography in diagnosing lipomatous hypertrophy of the atrial septum with comparison to transthoracic echocardiography. Am J Cardiol 1992;70:396-8. http://dx.doi.org/10.1016/0002-9149(92)90629-D
87. Reichek N, Devereux RB. Left ventricular hypertrophy: relationship of anatomic, echocardiographic and electrocardiographic findings. Circulation 1981;63:1391-8. http://dx.doi.org/10.1161/01. CIR.63.6.1391
88. Reichlin S, Dieterle T, Camli C, Leimenstoll B, Schoenenberger RA, Martina B. Initial clinical evaluation of cardiac systolic murmurs in the ED by noncardiologists. Am J Emerg Med 2004;22:71-5. http://dx.doi.org/10.1016/S0735-6757(03)00093-7
89. Roudaut RP, Billes MA, Gosse P, Deville C, Baudet E, Fontan F, et al. Accuracy of M-mode and twodimensional echocardiography in the diagnosis of aortic dissection: an experience with 128 cases. Clin Cardiol 1988;11:553-62. http://dx.doi.org/10.1002/clc.4960110809
90. Saraste M, Vesalainen RK, Ylitalo A, Saraste A, Koskenvuo JW, Toikka JO, et al. Transthoracic Doppler echocardiography as a noninvasive tool to assess coronary artery stenoses-a comparison with quantitative coronary angiography. J Am Soc Echocardiogr 2005;18:679-85. http://dx.doi. org/10.1016/j.echo.2004.09.016
91. Sharifi M, Parhizgar A, Gupta P, Mehdipour M, Emrani F, Baldwin D. Is transesophageal echocardiography necessary before D.C. cardioversion in patients with a normal transthoracic echocardiogram? Echocardiography 2007;24:397-400. http://dx.doi. org/10.1111/j.1540-8175.2007.00400.x
92. Sharma S, Krishnan U. Diagnosis of the sinus venosus defect by echocardiography and angiocardiography. Indian Heart J 1992;44:395-8.
93. Sheiban I, Casarotto D, Trevi G, Benussi P, Marini A, Accardi R, et al. Two-dimensional echocardiography in the diagnosis of intracardiac masses: a prospective study with anatomic validation. Cardiovasc Intervent Radiol 1987;10:157-61. http://dx.doi.org/10.1007/BF02577993
94. Shively BK, Gurule FT, Roldan CA, Leggett JH, Schiller NB, Shively BK, et al. Diagnostic value of transesophageal compared with transthoracic echocardiography in infective endocarditis. J Am Coll Cardiol 1991;18:391-7. http://dx.doi.org/10.1016/0735-1097(91)90591-V
95. Shrestha NK, Moreno FL, Narciso FV, Torres L, Calleja HB. Two-dimensional echocardiographic diagnosis of left-atrial thrombus in rheumatic heart disease. A clinicopathologic study. Circulation 1983;67:341-7. http://dx.doi.org/10.1161/01.CIR.67.2.341
96. Shub C, Dimopoulos IN, Seward JB, Callahan JA, Tancredi RG, Schattenberg TT, et al. Sensitivity of two-dimensional echocardiography in the direct visualization of atrial septal defect utilizing the subcostal approach: experience with 154 patients. J Am Coll Cardiol 1983;2:127-35. http://dx.doi. org/10.1016/S0735-1097(83)80385-4
97. Shyu KG, Lei M, Hwang J, Lin SC, Kuan P, Lien WP. Morphologic characterization and quantitative assessment of mitral regurgitation with ruptured chordae tendineae by transesophageal echocardiography. Am J Cardiol 1992;70:1152-6. http://dx.doi. org/10.1016/0002-9149(92)90047-3
98. Smith G, Endresen K, Sivertssen E, Semb G. Ventricular septal rupture diagnosed by simultaneous cross-sectional echocardiography and Doppler ultrasound. Eur Heart J 1985;6:631-6.
99. Sparrow N, Adlam D, Cowley A, Hampton JR. The diagnosis of heart failure in general practice: implications for the UK National Service Framework. Eur J Heart Fail 2003;5:349-54. http://dx.doi. org/10.1016/S1388-9842(03)00046-1
100. Stratton JR, Lighty GW Jr, Pearlman AS, Ritchie JL. Detection of left ventricular thrombus by two-dimensional echocardiography: sensitivity, specificity, and causes of uncertainty. Circulation 1982;66:156-66. http://dx.doi.org/10.1161/01.CIR.66.1.156
101. Veyrat C, Lessana A, Abitbol G, Ameur A, Benaim R, Kalmanson D, et al. New indexes for assessing aortic regurgitation with two-dimensional Doppler echocardiographic measurement of the regurgitant aortic valvular area. Circulation 1983;68:998-1005. http://dx.doi.org/10.1161/01. CIR.68.5.998
102. Vigna C, de Rito V, Criconia GM, Russo A, Testa M, Fanelli R, et al. Left atrial thrombus and spontaneous echo-contrast in nonanticoagulated mitral stenosis. A transesophageal echocardiographic study. Chest 1993;103:348-52. http://dx.doi.org/10.1378/chest.103.2.348
103. Wong M, Tei C, Shah PM. Sensitivity and specificity of two-dimensional echocardiography in the detection of valvular calcification. Chest 1983;84:423-7. http://dx.doi.org/10.1378/chest.84.4.423
104. Zanolla L, Marino P, Nicolosi GL, Peranzoni PF, Poppi A, Zanolla L, et al. Two-dimensional echocardiographic evaluation of mitral valve calcification. Sensitivity and specificity. Chest 1982;82:154-7. http://dx.doi.org/10.1378/chest.82.2.154
105. Zotz RJ, Dohmen G, Genth S, Erbel R, Dieterich HA, Meyer J. Transthoracic and transesophageal echocardiography to diagnose ventricular septal rupture: importance of right heart infarction. Coron Artery Dis 1993;4:911-17. http://dx.doi.org/10.1097/00019501-199310000-00011
106. Atrial Fibrillation Investigators. Echocardiographic predictors of stroke in patients with atrial fibrillation: a prospective study of 1066 patients from 3 clinical trials. Arch Intern Med 1998;158:1316-20. http://dx.doi.org/10.1001/archinte.158.12.1316
107. Klem I, Wehinger C, Schneider B, Hartl E, Finsterer J, Stollberger C, et al. Diabetic atrial fibrillation patients: mortality and risk for stroke or embolism during a 10-year follow-up. Diabetes Metabol Res Rev 2003;19:320-8. http://dx.doi.org/10.1002/dmrr.386
108. Miyasaka Y, Tsuji H, Tokunaga S, Nishiue T, Yamada K, Watanabe J, et al. Mild mitral regurgitation was associated with increased prevalence of thromboembolic events in patients with nonrheumatic atrial fibrillation. Int J Cardiol 2000;72:229-33.
109. Nakagami H, Yamamoto K, Ikeda U, Mitsuhashi T, Goto T, Shimada K, et al. Mitral regurgitation reduces the risk of stroke in patients with nonrheumatic atrial fibrillation. Am Heart J 1998;136:528-32. http://dx.doi.org/10.1016/S0002-8703(98)70231-5
110. The Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. Ann Intern Med 1992;116:6-12.
111. Agmon Y, Khandheria BK, Meissner I, Schwartz GL, Petterson TM, O'Fallon WM, et al. Association of atrial fibrillation and aortic atherosclerosis: a population-based study. Mayo Clin Proc 2001;76:252-9. http://dx.doi.org/10.4065/76.3.252
112. Archer SL, James KE, Kvernen LR, Cohen IS, Ezekowitz MD, Gornick CC. Role of transesophageal echocardiography in the detection of left atrial thrombus in patients with chronic nonrheumatic atrial fibrillation. Am Heart J 1995;130:287-95. http://dx.doi.org/10.1016/0002-8703(95)90442-5
113. Blackshear JL, Pearce LA, Hart RG, Zabalgoitia M, Labovitz A, Asinger RW, et al. Aortic plaque in atrial fibrillation: prevalence, predictors, and thromboembolic implications. Stroke 1999;30:834-40. http://dx.doi.org/10.1161/01.STR.30.4.834
114. Corrado GB. Prevalence of atrial thrombi in patients with atrial fibrillation/flutter and subtherapeutic anticoagulation prior to cardioversion. Eur J Echocardiogr 2004;5:257-61.
115. Dang D, Patel R. Atrial fibrillation in a multiethnic inpatient population of a large public hospital. J Natl Med Assoc 2004;96:1438-44.
116. Heppell RM, Berkin KE, McLenachan JM, Davies JA. Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation. Heart 1997;77:407-11.
117. Kleemann T, Becker T, Strauss M, Schneider S, Seidl K. Prevalence of left atrial thrombus and dense spontaneous echo contrast in patients with short-term atrial fibrillation 48 hours undergoing cardioversion: value of transesophageal echocardiography to guide cardioversion. J Am Soc Echocardiogr 2009;22:1403-8. http://dx.doi.org/10.1016/j.echo.2009.09.015
118. Levy S, Maarek M. Characterization of different subsets of atrial fibrillation in general practice in France: The ALFA study. Circulation 1999;99:3028-35. http://dx.doi.org/10.1161/01. CIR.99.23.3028
119. Lip GY, Golding DJ, Nazir M, Beevers DG, Child DL, Fletcher RI, et al. A survey of atrial fibrillation in general practice: the West Birmingham Atrial Fibrillation Project. Br J General Practice 1997;47:285-9.
120. Maltagliati AG. Usefulness of transoesophageal echocardiography before cardioversion in patients with atrial fibrillation and different anticoagulant regimens. Heart 2006;92:933-8.
121. Narumiya T, Sakamaki T, Sato Y, Kanmatsuse K. Relationship between left atrial appendage function and left atrial thrombus in patients with nonvalvular chronic atrial fibrillation and atrial flutter. Circ J 2003;67:68-72. http://dx.doi.org/10.1253/circj.67.68
122. Santiago D, Warshofsky M, Li MG, Di Tullio M, Coromilas J, Reiffel J, et al. Left atrial appendage function and thrombus formation in atrial fibrillation-flutter: a transesophageal echocardiographic study. J Am Coll Cardiol 1994;24:159-64. http://dx.doi.org/10.1016/0735-1097(94)90557-6
123. Scherr D, Dalal D, Chilukuri K, Dong J, Spragg D, Henrikson CA, et al. Incidence and predictors of left atrial thrombus prior to catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2009;20:379-84. http://dx.doi.org/10.1111/j.1540-8167.2008.01336.x
124. Shen X, Li H, Rovang K, Holmberg MJ, Mooss AN, Mohiuddin SM. Prevalence of intra-atrial thrombi in atrial fibrillation patients with subtherapeutic international normalized ratios while taking conventional anticoagulation. Am J Cardiol 2002;90:660-2.
125. Tsai LM, Lin LJ, Teng JK, Chen JH. Prevalence and clinical significance of left atrial thrombus in nonrheumatic atrial fibrillation. Int J Cardiol 1997;58:163-9. http://dx.doi.org/10.1016/ S0167-5273(96)02862-8
126. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008;61:344-9. http://dx.doi.org/10.1016/j. jclinepi.2007.11.008
127. Stroke Prevention in Atrial Fibrillation Investigators. The Stroke Prevention in Atrial Fibrillation III randomized clinical trial: background, design and patient characteristics of the Stroke Prevention in Atrial Fibrillation III study. J Stroke Cerebrovasc Dis 1996;6:341-53.
128. Higashiue S, Watanabe H, Yokoi Y, Takeuchi K, Yoshikawa J. Simple detection of severe coronary stenosis using transthoracic Doppler echocardiography at rest. Am J Cardiol 2001;87:1064-8. http://dx.doi.org/10.1016/S0002-9149(01)01462-X
129. Garg R, Khaja A, Madsen R, Alpert MA, Tejwani L, Aggarwal K, et al. Observer variation in the echocardiographic measurement of maximum atrial septal excursion: a comparison of M-mode with two-dimensional or transesophageal echocardiography. Echocardiography 2009;26:1122-6. http://dx.doi.org/10.1111/j.1540-8175.2009.00964.x
130. Hirata K, Pulerwitz T, Sciacca R, Otsuka R, Oe Y, Fujikura K, et al. Clinical utility of new real time three-dimensional transthoracic echocardiography in assessment of mitral valve prolapse. Echocardiography 2008;25:482-8. http://dx.doi.org/10.1111/j.1540-8175.2008.00630.x
131. Miniati M, Monti S, Pratali L, Di Ricco G, Marini C, Formichi B, et al. Value of transthoracic echocardiography in the diagnosis of pulmonary embolism: results of a prospective study in unselected patients. Am J Med 2001;110:528-35. http://dx.doi.org/10.1016/ S0002-9343(01)00693-3
132. Chamoun AJ, McCulloch M, Xie T, Shah S, Ahmad M. Real-time three-dimensional echocardiography versus two-dimensional echocardiography in the diagnosis of left ventricular apical thrombi: preliminary findings. J Clin Ultrasound 2003;31:412-18. http://dx.doi.org/10.1002/ jcu.10199
133. Shiga T, Wajima Z, Inoue T, Ogawa R. Survey of observer variation in transesophageal echocardiography: comparison of anesthesiology and cardiology literature. J Cardiothorac Vasc Anesth 2003;17:430-42. http://dx.doi.org/10.1016/S1053-0770(03)00146-0
134. Frykman V, Frick M, Jensen-Urstad M, Ostergren J, Rosenqvist M. Asymptomatic versus symptomatic persistent atrial fibrillation: clinical and noninvasive characteristics. J Intern Med 2001;250:390-7. http://dx.doi.org/10.1046/j.1365-2796.2001.00893.x
135. Rozenberg V, Boccara F, Benhalima B, Lamisse N, Buyukoglu B, Cohen A, et al. Comparison of echocardiographic markers of embolism in atrial flutter and fibrillation: frequency of protruding atherosclerotic plaques in the thoracic aorta. Echocardiography 2000;17:555-62. http://dx.doi. org/10.1046/j.1540-8175.2000.00555.x
136. DiPasquale G, Urbinati S, Pinelli G. New echocardiographic markers of embolic risk in atrial fibrillation. Cerebrovasc Dis 1995;5:315-22. http://dx.doi.org/10.1159/000107874
137. Rubin DN, Katz SE, Riley MF, Douglas PS, Manning WJ. Evaluation of left atrial appendage anatomy and function in recent-onset atrial fibrillation by transesophageal echocardiography. Am J Cardiol 1996;78:774-8. http://dx.doi.org/10.1016/S0002-9149(96)00419-5
138. Black IW, Hopkins AP, Lee LC, Walsh WF. Evaluation of transesophageal echocardiography before cardioversion of atrial fibrillation and flutter in nonanticoagulated patients. Am Heart J 1993;126:375-81. http://dx.doi.org/10.1016/0002-8703(93)91054-I
139. Rostagno C, Galanti G, Bertini G, Olivo G, Gensini GF. Doppler echocardiography in suspected lone atrial fibrillation. Angiology 1998;49:637-40. http://dx.doi.org/10.1177/000331979804900808
140. Levy S. Epidemiology and classification of atrial fibrillation. J Cardiovasc Electrophysiol 1998;9(Suppl. 8):S78-82.
141. Tops LF, Schalij MJ, Bax JJ. Imaging and atrial fibrillation: the role of multimodality imaging in patient evaluation and management of atrial fibrillation. Eur Heart J 2010;31:542-51. http://dx.doi. org/10.1093/eurheartj/ehq005
142. Tsang TS, Miyasaka Y, Barnes ME, Gersh BJ. Epidemiological profile of atrial fibrillation: a contemporary perspective. Prog Cardiovasc Dis 2005;48:1-8. http://dx.doi.org/10.1016/j. pcad.2005.06.001
143. National Institute for Health and Care Excellence (NICE). Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation. NICE technology appraisal guidance 249. 2012. URL: www.nice.org.uk/nicemedia/live/13677/58470/58470.pdf (accessed 28 September 2012).
144. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. Ann Intern Med 1998;128:639-47.
145. Office for National Statistics (ONS). Life tables. URL: www.ons.gov.uk/ons/rel/lifetables/interim-lifetables/ 2008-2010/index.html (accessed February 2012).
146. Friberg L, Rosenqvist M, Lip G. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Eur Heart J 2012;33:1500-10. http://dx.doi.org/10.1093/eurheartj/ehr488
147. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139-51. http://dx.doi. org/10.1056/NEJMoa0905561
148. Lip G, Edwards S. Stroke prevention with aspirin, warfarin and ximelagatran in patients with nonvalvular atrial fibrillation: a systematic review and meta-analysis. Thromb Res 2006;118:321-33. http://dx.doi.org/10.1016/j.thromres.2005.08.007
149. Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011;365:883-91. http://dx.doi.org/10.1056/ NEJMoa1009638
150. Eikelboom JW, Wallentin L, Connolly SJ, Ezekowitz M, Healey JS, Oldgren J, et al. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial. Circulation 2011;123:2363-72. http://dx.doi.org/10.1161/CIRCULATIONAHA.110.004747
151. London New Drugs Group. A briefing paper on dabigatran and rivaroxaban: what we know so far. UK Medicines Information (UKMi); 2012. URL: www.medicinesresources.nhs.uk/upload/Dabigatran_ and_rivaroxaban_briefing_Jan12.pdf (accessed April 2013).
152. British Medical Association and Royal Pharmaceutical Society of Great Britain. British national formulary. London: BMA and RPS; 2011. URL: www.medicinescomplete.com/mc/bnf/current/ PHP1497-warfarin-non-proprietary.htm
153. Department of Health (DoH). NHS reference costs 2009-2010. London: DoH; 2010.
154. Rivero-Arias O, Ouellet M, Gray A, Wolstenholme J, Rothwell P, Luengo-Fernandez R. Mapping the modified Rankin Scale (mRS) Measurement into the Generic EuroQol (EQ-5D) Health Outcome. Med Decis Making 2010;30:341-54. http://dx.doi.org/10.1177/0272989X09349961
155. Dorman P, Dennis M, Sandercock P. Are the modified 'simple questions' a valid and reliable measure of health related quality of life after stroke? J Neurol Neurosurg Psychiatr 2000;69:487-93. http:// dx.doi.org/10.1136/jnnp.69.4.487
156. Sandercock P, Berge E, Dennis M, Forbes J, Hand P, Kwan J, et al. A systematic review of the effectiveness, cost-effectiveness and barriers to implementation of thrombolytic and neuroprotective therapy for acute ischaemic stroke in the NHS. Health Technol Assess 2002;6(26).
157. Curtis L. Unit costs of health and social care 2010. Canterbury: PSSRU, University of Kent; 2011.
158. Simpson E, Stevenson M, Rawdin A, Papaioannou D. Thrombophilia testing in people with venous thromboembolism: systematic review and cost-effectiveness analysis. Health Technol Assess 2009;13(2).
159. Linkins LA, Choi PT, Douketis JD. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism. Ann Intern Med 2003;139:893-900.
160. Haselsberger K, Pucher R, Auer LM. Prognosis after acute subdural or epiduralhaemorrhage. Acta Neurochir (Wien) 1988;90:111-16. http://dx.doi.org/10.1007/BF01560563
161. Holmes M, Goodacre S, Stevenson M, Pandor A, Pickering A. The cost-effectiveness of diagnostic management strategies for adults with minor head injury. Injury 2012;43:1423-31. http://dx.doi. org/10.1016/j.injury.2011.07.017
162. Goodacre S, Stevenson M, Wailoo A, Sampson F, Sutton AJ, Thomas S. How should we diagnose suspected deep-vein thrombosis? QJM 2006;99:377-88. http://dx.doi.org/10.1093/qjmed/hcl051
163. Meenan RT, Saha S, Chou R, Swarztrauber K, Pyle Krages K, O'Keeffe-Rosetti MC, et al. Costeffectiveness of echocardiography to identify intracardiac thrombus among patients with first stroke or transient ischemic attack. Med Decis Making 2007;27:161-77. http://dx.doi. org/10.1177/0272989X06297388
164. National Institute for Health and Care Excellence (NICE). Guide to the methods of technology appraisals. London: NICE; 2008.
165. Fenwick E, Claxton K, Sculpher MJ. Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ 2001;10:779-87. http://dx.doi.org/10.1002/hec.635
166. Claxton K, Posnett J. An economic approach to clinical trial design and research priority-setting. Health Econ 1996;5:513-24. http://dx.doi.org/10.1002/ (SICI)1099-1050(199611)5:6(513::AID-HEC23753.0.CO;2-9
167. Felli JC, Hazen BG. Sensitivity analysis and the expected value of perfect information. Med Decis Making 1998;18:95-109. http://dx.doi.org/10.1177/0272989X9801800117
168. Spain MG, Smith MD, Graybum PA, Harlamert EA, Demaria AN. Quantitative assessment of mitral regurgitation by Doppler color flow imaging: angiographic and hemodynamic correlations. J Am Coll Cardiol 1989;13:585-90. http://dx.doi.org/10.1016/0735-1097(89)90597-4
169. Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. Transesophageal echocardiography in atrial fibrillation: standards for acquisition and interpretation and assessment of interobserver variability. J Am Soc Echocardiogr 1996;9:556-66.
170. Abbasi AS, Allen MW, DeCristofaro D, Ungar I. Detection and estimation of the degree of mitral regurgitation by range-gated pulsed doppler echocardiography. Circulation 1980;61:143-7. http:// dx.doi.org/10.1161/01.CIR.61.1.143
171. Aghassi P, Aurigemma GP, Folland ED, Tighe DA. Catheterization-Doppler discrepancies in nonsimultaneous evaluations of aortic stenosis. Echocardiography 2005;22:367-73. http://dx.doi. org/10.1111/j.1540-8175.2005.04006.x
172. Agricola E, Meris A, Oppizzi M, Bombardini T, Pisani M, Fragasso G, et al. Rest and stress echocardiographic predictors of prognosis in patients with left ventricular dysfunction and functional mitral regurgitation. Int J Cardiol 2008;124:247-9. http://dx.doi.org/10.1016/j. ijcard.2006.11.234
173. Alkadhi H, Desbiolles L, Husmann L, Plass A, Leschka S, Scheffel H, et al. Aortic regurgitation: assessment with 64-section CT. Radiology 2007;245:111-21. http://dx.doi.org/10.1148/ radiol.2451061523
174. Assey ME, Usher BW. Echocardiography in diagnosing and managing aortic valve endocarditis. South Med J 1981;74:558-65. http://dx.doi.org/10.1097/00007611-198105000-00014
175. Babic UU, Popovic Z, Vucinic M, Djurisic Z, Pejcic P, Grujicic S, et al. Selective coronary angiography versus two-dimensional echocardiography for diagnosis of left atrial thrombi. Angiology 1991;42:889-98. http://dx.doi.org/10.1177/000331979104201104
176. Badran HM, Mostafa A, Serage A, Fareed W, Abdelfatah E, Fathe A. Arterial mechanics in ischemic versus nonischemic cardiomyopathy: clinical and diagnostic impact. Echocardiography 2009;26:785-800. http://dx.doi.org/10.1111/j.1540-8175.2008.00888.x
177. Blanchard D, Diebold B, Peronneau P, Foult JM, Nee M, Guermonprez JL, et al. Non-invasive diagnosis of mitral regurgitation by Doppler echocardiography. Br Heart J 1981;45:589-93. http:// dx.doi.org/10.1136/hrt.45.5.589
178. Blot-Souletie N, Hebrard A, Acar P, Carrie D, Puel J. Comparison of accuracy of aortic valve area assessment in aortic stenosis by real time three-dimensional echocardiography in biplane mode versus two-dimensional transthoracic and transesophageal echocardiography. Echocardiography 2007;24:1065-72. http://dx.doi.org/10.1111/j.1540-8175.2007.00526.x
179. Bogren HG, Demaria AN, Mason DT. Imaging procedures in the detection of cardiac tumors, with emphasis on echocardiography: a review. Cardiovasc Intervent Radiol 1980;3:107-25. http://dx.doi. org/10.1007/BF02552329
180. Buchner S, Debl K, Poschenrieder F, Feuerbach S, Riegger GA, Luchner A, et al. Cardiovascular magnetic resonance for direct assessment of anatomic regurgitant orifice in mitral regurgitation. Circ Cardiovasc Imaging 2008;1:148-55. http://dx.doi.org/10.1161/CIRCIMAGING.107.753103
181. Casiglia E, Schiavon L, Tikhonoff V, Bascelli A, Martini B, Mazza A, et al. Electrocardiographic criteria of left ventricular hypertrophy in general population. Eur J Epidemiol 2008;23:261-71. http:// dx.doi.org/10.1007/s10654-008-9234-6
182. Charron P, Dubourg O, Desnos M, Isnard R, Hagege A, Millaire A, et al. Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in a genotyped adult population. Circulation 1997;96:214-19. http://dx.doi.org/10.1161/01.CIR.96.1.214
183. Chen YZ, Sherrid MV, Dwyer EM Jr. Value of two-dimensional echocardiography in evaluating coronary artery disease: a randomized blinded analysis. J Am Coll Cardiol 1985;5:911-17. http:// dx.doi.org/10.1016/S0735-1097(85)80432-0
184. Egeblad H, Berning J, Saunamaki K, Jacobsen JR, Wennevold A. Assessment of rheumatic mitral valve disease. Value of echocardiography in patients clinically suspected of predominant stenosis. Br Heart J 1983;49:38-44. http://dx.doi.org/10.1136/hrt.49.1.38
185. Fleischmann KE, Goldman L, Robiolio PA, Lee RT, Johnson PA, Cook EF, et al. Echocardiographic correlates of survival in patients with chest pain. J Am Coll Cardiol 1994;23:1390-6. http://dx.doi. org/10.1016/0735-1097(94)90382-4
186. Gonzalez-Torrecilla E, Garcia-Fernandez MA, Perez-David E, Bermejo J, Moreno M, Delcan JL, et al. Predictors of left atrial spontaneous echo contrast and thrombi in patients with mitral stenosis and atrial fibrillation. Am J Cardiol 2000;86:529-34. http://dx.doi.org/10.1016/S0002-9149(00)01007-9
187. Hsiao SH, Chang SM, Lee CY, Yang SH, Lin SK, Chiou KR, et al. Usefulness of tissue Doppler parameters for identifying pulmonary embolism in patients with signs of pulmonary hypertension. Am J Cardiol 2006;98:685-90. http://dx.doi.org/10.1016/j.amjcard.2006.03.053
188. Irani WN, Grayburn PA, Afridi I, Irani WN, Grayburn PA, Afridi I. A negative transthoracic echocardiogram obviates the need for transesophageal echocardiography in patients with suspected native valve active infective endocarditis. Am J Cardiol 1996;78:101-3. http://dx.doi. org/10.1016/S0002-9149(96)00236-6
189. Khanna D, Vengala S, Miller AP, Nanda NC, Lloyd SG, Ahmed S, et al. Quantification of mitral regurgitation by live three-dimensional transthoracic echocardiographic measurements of vena contracta area. Echocardiography 2004;21:737-43. http://dx.doi. org/10.1111/j.0742-2822.2004.40027.x
190. Khumri TM, Idupulapati M, Rader VJ, Nayyar S, Stoner CN, Main ML, et al. Clinical and echocardiographic markers of mortality risk in patients with atrial fibrillation. Am J Cardiol 2007;99:1733-6. http://dx.doi.org/10.1016/j.amjcard.2007.01.055
191. Kruger S, Haage P, Hoffmann R, Breuer C, Bucker A, Hanrath P, et al. Diagnosis of pulmonary arterial hypertension and pulmonary embolism with magnetic resonance angiography. Chest 2001;120:1556-61. http://dx.doi.org/10.1378/chest.120.5.1556
192. Lembcke A, Thiele H, Lachnitt A, Enzweiler CN, Wagner M, Hein PA, et al. Precision of forty slice spiral computed tomography for quantifying aortic valve stenosis: comparison with echocardiography and validation against cardiac catheterization. Investig Radiol 2008;43:719-28. http://dx.doi.org/10.1097/RLI.0b013e318184d7c5
193. Meng Q, Lai H, Lima J, Tong W, Qian Y, Lai S, et al. Echocardiographic and pathologic characteristics of primary cardiac tumors: a study of 149 cases. Int J Cardiol 2002;84:69-75. http://dx.doi. org/10.1016/S0167-5273(02)00136-5
194. Miyatake K, Izumi S, Okamoto M, Kinoshita N, Asonuma H, Nakagawa H, et al. Semiquantitative grading of severity of mitral regurgitation by real-time two-dimensional Doppler flow imaging technique. J Am Coll Cardiol 1986;7:82-8. http://dx.doi.org/10.1016/S0735-1097(86)80263-7
195. Mogelvang R, Sogaard P, Pedersen SA, Olsen NT, Marott JL, Schnohr P, et al. Cardiac dysfunction assessed by echocardiographic tissue Doppler imaging is an independent predictor of mortality in the general population. Circulation 2009;119:2679-85. http://dx.doi.org/10.1161/ CIRCULATIONAHA.108.793471
196. Nitta M, Takamoto T, Taniguchi K, Hultgren HN. Diagnostic accuracy of continuous wave Doppler echocardiography in severe aortic stenosis in the elderly. Japanese Heart J 1988;29:169-78. http:// dx.doi.org/10.1536/ihj.29.169
197. Pechacek LW. Comparison of two-dimensional echocardiography, radionuclide ventriculography and cineangiography in detecting surgically documented left ventricular thrombi. Texas Heart Inst J 1984;11:118-27.
198. Peteiro J, Bendayan I, Marinas J, Campos R, Bouzas B, Castro-Beiras A, et al. Prognostic value of mitral regurgitation assessment during exercise echocardiography in patients with left ventricular dysfunction: a follow-up study of 1.7+/-1.5 years. Eur J Echocardiogr 2008;9:18-25.
199. Roe MT, Abramson MA, Li J, Heinle SK, Kisslo J, Corey GR, et al. Clinical information determines the impact of transesophageal echocardiography on the diagnosis of infective endocarditis by the duke criteria. Am Heart J 2000;139:945-51. http://dx.doi.org/10.1067/mhj.2000.104762
200. Sallach JA, Puwanant S, Drinko JK, Jaffer S, Donal E, Thambidorai SK, et al. Comprehensive left atrial appendage optimization of thrombus using surface echocardiography: the CLOTS multicenter pilot trial. J Am Soc Echocardiogr 2009;22:1165-72. http://dx.doi.org/10.1016/j.echo.2009.05.028
201. Stafford WJ, Petch J, Radford DJ. Vegetations in infective endocarditis. Clinical relevance and diagnosis by cross sectional echocardiography. Br Heart J 1985;53:310-13. http://dx.doi. org/10.1136/hrt.53.3.310
202. Steckelberg JM, Murphy JG, Ballard D, Bailey K, Tajik AJ, Taliercio CP, et al. Emboli in infective endocarditis: the prognostic value of echocardiography. Ann Intern Med 1991;114:635-40.
203. Stevens SM, Farzaneh-Far R, Na B, Whooley MA, Schiller NB. Development of an echocardiographic risk-stratification index to predict heart failure in patients with stable coronary artery disease: the Heart and Soul study. JACC Cardiovasc Imag 2009;2:11-20. http://dx.doi.org/10.1016/j. jcmg.2008.08.004
204. Takamoto T, Kim D, Urie PM, Guthaner DF, Gordon HJ, Keren A, et al. Comparative recognition of left ventricular thrombi by echocardiography and cineangiography. Br Heart J 1985;53:36-42. http://dx.doi.org/10.1136/hrt.53.1.36
205. Thuny F, Di Salvo G, Belliard O, Avierinos JF, Pergola V, Rosenberg V, et al. Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study. Circulation 2005;112:69-75. [Erratum published in Circulation 2005;112:e125] http://dx.doi. org/10.1161/CIRCULATIONAHA.104.493155
206. Visser CA, Kan G, David GK, Lie KI, Durrer D. Two dimensional echocardiography in the diagnosis of left ventricular thrombus. A prospective study of 67 patients with anatomic validation. Chest 1983;83:228-32. http://dx.doi.org/10.1378/chest.83.2.228
207. Willens HJ, Chirinos JA, Schob A, Veerani A, Perez AJ, Chakko S, et al. The relation between mitral annular calcification and mortality in patients undergoing diagnostic coronary angiography. Echocardiography 2006;23:717-22. http://dx.doi.org/10.1111/j.1540-8175.2006.00300.x
208. Colkesen Y, Acil T, Demircan S, Sezgin AT, Ozin B, Muderrisoglu H, et al. Echocardiographic features of patients with paroxysmal atrial fibrillation. Int J Cardiovasc Imag 2008;24:159-63. http://dx.doi. org/10.1007/s10554-007-9247-3
209. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey K, Seward J, et al. Coronary ischemic events after first atrial fibrillation: risk and survival. Am J Med 2007;120:357-63. http://dx.doi.org/10.1016/j. amjmed.2006.06.042
210. Simpson EL, Stevenson MD, Rawdin A, Papaioannou D. Thrombophilia testing in people with venous thromboembolism: systematic review and cost-effectiveness analysis. Health Technol Assess 2009:13(2).
211. Ara R, Brazier JE. Populating an economic model with health state utility values: moving toward better practice. Value Health 2010;13:509-18. http://dx.doi. org/10.1111/j.1524-4733.2010.00700.x
212. National Institute for Health and Care Excellence (NICE). Atrial fibrillation-dabigatran etexilate (TA249). URL: www.nice.org.uk/TA249 (accessed March 2012).
213. Department of Health (DoH). Impact assessment: national stroke strategy. 2007. URL: http:// webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/prod_consum_dh/ groups/dh_digitalassets/documents/digitalasset/dh_081054.pdf (accessed April 2013).